- Home
- Media Center
- Press releases
- Innovative Medicine
Innovative Medicine
Casey Abrams Announces Finalists in National Inflammatory Bowel Disease Awareness Campaign and Calls on America to Vote
After opening up about his own battle with Ulcerative Colitis, season 10 American Idol contestant Casey Abrams pledges to shave his signature beard if 1,500 people join the cause at IBDIcons.com
EDURANT® (Rilpivirine) Receives Positive Opinion from the Committee for Medicinal Products for Human Use (CHMP) For Use in Treatment-Naïve Adults with HIV-1
Third HIV medication submitted by Tibotec
REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis
Approval Expands Access to REMICADE for Children Living with Ulcerative Colitis
Health Canada Approves Expanded Indication For SIMPONI®* To Include Inhibition Of Structural Damage In The Treatment Of Moderately To Severely Active Rheumatoid Arthritis
SIMPONI® Indication Also Expanded To Include Improvement In Physical Function
INCIVO® (Telaprevir) Approved In Europe Offering Higher Cure Rates For Genotype-1 Chronic Hepatitis C Compared To Standard Treatment
New treatment options increase chance of a cure
24 Week Incivo® (Telaprevir)-Based Regimen Effective For Majority Of Previously Untreated Genotype-1 Chronic HCV Patients
ILLUMINATE Phase 3 Study Published In New England Journal Of Medicine
Johnson & Johnson Symposium Honors 2011 Recipient Of The Dr. Paul Janssen Award For Biomedical Research
Ferrara Honored For Unlocking Key To Novel Anti-Angiogenesis Therapies